Outcomes of Treatment for Malignant Peripheral Nerve Sheath Tumors: Different Clinical Features Associated with Neurofibromatosis Type 1
Cancer Research and Treatment. 2017;49(3):717-726 
Current status of sporadic and neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors
Current Oncology Reports. 2009;11(4):322-328
Somatic Copy Number Alterations: Gene and Protein Expression Correlates in NF1-Associated Malignant Peripheral Nerve Sheath Tumors
Neurofibromatosis Type 1. 2012;405-428
Genomics of Peripheral Nerve Sheath Tumors Associated with Neurofibromatosis Type 1
Multidisciplinary Approach to Neurofibromatosis Type 1. 2020;117-147
Ras Signaling Pathway in Biology and Therapy of Malignant Peripheral Nerve Sheath Tumors
Neurofibromatosis Type 1. 2012;589-609
Peripheral nerve sheath tumors in Neurofibromatosis Type 2: Surgical and histopathologic features
Clinical Neurology and Neurosurgery. 2020;190:105649
JS03.5.A Pediatric Neurofibromatosis type 1- associated Malignant Peripheral Nerve Sheath Tumors: a national experience
Neuro-Oncology. 2022;24(Supplement_2):ii6-ii6
NFM-05. CANCER STEM CELLS PROMOTE RELAPSE IN NEUROFIBROMATOSIS TYPE 1 ASSOCIATED MALIGNANT PERIPHERAL NERVE SHEATH TUMORS
Neuro-Oncology. 2018;20(suppl_2):i143-i143
Treatment of neurofibromatosis 1-associated malignant peripheral nerve sheath tumors: a systematic review
Neurosurgical Review. 2019;43(4):1039-1046
Different sized somatic NF1 locus rearrangements in neurofibromatosis 1-associated malignant peripheral nerve sheath tumors
Journal of Neuro-Oncology. 2010;102(3):341-346